Basics Acrivon Therapeutics, Inc. IPO Date: November 15, 2022 Sector: Healthcare Industry: Biotech Market Cap: $48.6M Activated in VL: True Average Daily Range Avg Daily Range: $0.35 | 4.14% Avg Daily Range (30 D): $0.19 | 8.80% Avg Daily Range (90 D): $0.22 | 5.61% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): .72M Avg Daily Volume (90 D): .27M Trade Size Avg Trade Size (Sh.): 101 Avg Trade Size (Sh.) (30 D): 165 Avg Trade Size (Sh.) (90 D): 150 Institutional Trades Total Inst.Trades: 19 Avg Inst. Trade: $2.35M Avg Inst. Trade (30 D): $.55M Avg Inst. Trade (90 D): $.94M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.29M Avg Closing Trade (30 D): $.55M Avg Closing Trade (90 D): $.82M Avg Closing Volume: 265.96K         News Sep 14, 2024 @ 7:10 AM Acrivon Therapeutics Reports Positive Endometrial ... Source: N/A Jul 10, 2024 @ 1:01 PM Athira (ATHA) Completes Dosing in Alzheimer's Stud... Source: N/A Jul 5, 2024 @ 1:31 PM AstraZeneca's (AZN) Tagrisso Gets EU Nod for First... Source: N/A Jul 2, 2024 @ 4:12 PM SpringWorks (SWTX) Completes NDA Submission for Mi... Source: Zacks Equity Research Jul 2, 2024 @ 3:00 PM AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for ... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-2.38 $-.59 $-2.38 Diluted EPS $-2.38 $-.59 $-2.38 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -80.56M $ -22.83M $ -80.56M Operating Income / Loss $ -89.2M $ -24.95M $ -89.2M Cost of Revenue $ $ $ Net Cash Flow $ 3.59M $ -3.6M $ 3.59M PE Ratio